Effects of quercetin on insulin-like growth factors (IGFs) and their binding protein-3 (IGFBP-3) secretion and induction of apoptosis in human prostate cancer cells

Journal of Carcinogenesis

Volumn 5, Issue , 2006, Pages

  Vijayababu, Marati R ^a   Arunkumar, A ^a   Kanagaraj, P ^a   Arunakaran, J ^a  

^a UNIVERSITY OF MADRAS   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; DNA FRAGMENT; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN P53; QUERCETIN; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNORADIOMETRIC ASSAY; MALE; NICK END LABELING; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN SECRETION; WESTERN BLOTTING;

EID: 33745655837     PISSN: 14773163     EISSN: 14773163     Source Type: Journal    
DOI: 10.1186/1477-3163-5-10     Document Type: Article

References (41)

1. Kefford JF: Citrus fruits and processed citrus products in human nutrition. World Rev Nutr Diet 1996, 6:197-249.
2. Yoshida M, Yarnmoto M, Nikaido T: Quercetin arrest leukemic T-cells in late G1 phase of the cell cycle. Cancer Res 1992, 52:6676-6681.
3. Csokay B, Prajda N, Weber G, Olah E: Molecular mechanisms in the antiproliferative action of quercetin. Life Sci 1997, 60:2157-2163.
4. Wang S, DeGroff VL, Clinton SK: Tomato and soy polyphenols reduce insulin-like growth factor-1-stimulated rat prostate cancer cell proliferation and apoptotic resistance in vitro via inhibition of intracellular signaling pathways involving tyrosine kinase. J Nutr 2003, 133:2367-2376.
5. De Mellow JS, Baxter RC: Growth hormone-dependent insulin-like growth factor (IGF) binding protein both inhibits and potentiates IGIF-1-stimulated DNA synthesis in human skin fibroblasts. Biochem Biophys Res Commun 1988, 156:199-204.
6. Conover CA: Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology 1992, 130:3191-3199.
7. Kaicer E, Blat C, Harel L: IGF-1 and IGF-binding proteins: stimulatory and inhibitory factors secreted by human prostatic adenocarcinoma cells. Growth Factors 1991, 4:231-237.
8. Rajah R, Khare A, Lee PD, Cohen P: Insulin-like growth factor-binding protein-3 is partially responsible for high-serum-induced apoptosis in PC-3 prostate cancer cells. J Endocrinol 1999, 163:487-494.
9. Hong J, Zhang G, Dong F, Rechler MM: Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-1 or IGF-11 stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002, 277:10489-10497.
10. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-1 receptor gene. Mol Endocrinol 1995, 9:361-367.
11. Rajah R, Lee KW, Cohen P: Insulin-like growth factor binding protein-3 mediates tumor necrosis factor-alpha-induced apoptosis: role of Bcl-2 phosphorylation. Cell Growth Differ 2002, 13:163-171.
12. Rajah R, Valentinis B, Cohen P: Insulin-like growth factor binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism. J Biol Chem 1997, 272:12181-12188.
13. Angelloz-Nicoud P, Binoux M: Autocrine regulation of cell proliferation by theinsulin-like growth factor (IGF) and IGF binding protein-3 protease system in a human prostate carcinoma cell line (PC-3). Endocrinology 1995, 136:5485-5492.
14. Oh Y, Muller HL, Ng L, Rosenfeld R: Transforming growth factor-ßinduced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J Biol Chem 1995, 270:13589-13592.
15. Huynh H, Pollak M, Zhang JC: Regulation of insulin-like growth factor (IGF) 1 and IGF binding protein-3 autocrine loop in human PC-3 prostate cancer cells by vitamin D metabolite 1,25 (OH) 2D3 and its analog EB1089. Int J Oncol 1998, 13:137-143.
16. Gill ZP, Perks CM, Newcomb PV, Holly JMP: Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in an non-IGF- dependent manner. J Biol Chem 1997, 272:25602-25607.
17. Gucev ZS, Oh Y, Kelley KM, Rosenfeld RG: Insulin-like growth factor binding protein-3 mediates retinoic acid- and transforming growth factor β2-induced growth inhibition in human breast cancer cells. Cancer Res 1996, 56:1545-1550.
18. Rozen F, Zhang J, Pollak M: Antiproliferative action of tumor necrosis factor-α on MCF-7 breast cancer cells is associated with increased insulin-like growth factor binding protein-3 accumulation. Int J Oncol 1998, 13:865-869.
19. Buckbinder L, Talbott R, Velasco-Miguel S, Takenaka I, Faha B, Seizinger R, Kley N: Induction of the growth inhibitor IGF-binding protein-3 by p53. Nature 1995, 377:646-649.
20. Bromfield GP, Meng A, Warde P, Bristow RG: Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill. Prostate Cancer Prostatic Diseases 2003, 6:73-85.
21. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6.
22. Li X, Marani M, Yu J, Nan B, Roth JA, Kagawa S, Fang B, Denner L, Marcelli M: Adenovirus-mediated Bax overexpression for the induction of therapeutic apoptosis in prostate cancer. Cancer Res 2001, 61:186-191.
23. Catz SD, Johnson JL: BCL-2 in prostate cancer: a minireview. Apoptosis 2003, 8:29-37.
24. Vijayababu MR, Kanagaraj P, Arunkumar A, Srinivasan N, Michael Aruldhas M, Arunakaran J: Effects of quercetin on IGF system components in PC-3 cells. XXII symposium of the Society for Reproductive Biology and Comparative Endocrinology (SRBCE) 2004:30-31. Chennai, India.
25. Martin JL, Pattison SL: Insulin-like growth factor binding protein-3 is regulated by dihydrotestosterone and stimulates deoxyribonucleic acid synthesis and cell proliferation in LNCaP prostate carcinoma cell. Endocrinology 2000, 141:2401-2409.
26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin-phenol reagent. J Biol Chem 1951, 193:265-270.
27. Baxter RC: Signalling pathways involved in antiproliferative effects of IGFBP-3: a review. Mol Pathol 1997, 54:145-148.
28. Singleton JR, Dixit VM, Feldman EL: Type I Insulin-like Growth Factor Receptor Activation Regulates Apoptotic Proteins. J Biol Chem 1996, 271:31791-31794.
29. L Gene Product. Endocrinology 1997, 138:1355-1358.
30. Butt AJ, Firth SM, Baxter RC: The IGF axis and programmed cell death. Immunol Cell Biol 1999, 77:256-262.
31. Smith GD, Gunnell D, Holly J: Cancer and insulin-like growth factor-1. BMJ 2000, 321:847-848.
32. Djavan B, Bursa B, Seitz C, Soeregi G, Remzi M, Bhaskhah M: Insulin like growth factor-1 (IGF-1), IGF-1 density and IGF/PSA ratio for prostate cancer detection. Urology 1999, 54:603-606.
33. Klein RD, Fischer SM: Black tea polyphenols inhibit IGF-1 induced signaling pathway through Akt in normal prostate epithelial cells and Du145 prostate carcinoma cells. Carcinogenesis 2002, 23:217-221.
34. Singh RP, Dhanalaksmi S, Tyagi AK, Chan DCF, Agarwal C, Agarwal R: Dietary feeding of silibinin inhibits advance human prostate carcinoma growth in athymic nude mice and increases plasma insulin-like growth factor-binding protein-3 levels. Cancer Res 2002, 62:3061-3069.
35. Jackson JG, White MF, Yee D: Insulin receptor substrate-1 is the predominant signaling molecule activated by insulin-like growth factor-1, insulin, and interleukin-4 in estrogen receptor-positive human breast cancer cells. J Biol Chem 1998, 273:9994-10003.
36. Baserga R: The IGF-1 receptor in cancer research. Exp Cell Res 1999, 253:1-6.
37. Chan JM, Stampfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M: Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998, 279:563-566.
38. Pollak M: Insulin-like growth factor physiology and cancer risk. Eur J Cancer 2000, 36:1224-1228.
39. Hollowood AD, Lai T, Perks CM, Newcomb PV, Alderson D, Holly JM: IGFBP-3 prolongs the p53 response and enhances apoptosis following UV irradiation. IntJ Cancer 2000, 88:336-341.
40. Devi GR, Sprenger CC, Plymate SP, Rosenfeld RG: IGFBP-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vitro. Prostate 2002, 51:141-152.
41. Lee DY, Yi HK, Hwang PH, Oh Y: Enhanced expression of IGFBP-3 sensitizes the growth inhibiting effect of anticancer drugs in gastric cancer cells. Biochem Biophys Res Commun 2002, 294:480-486.